Journal of the American Chemical Society · 2017 · 376 citations · 29 references
MedicineBiochemistryPharmacologyDrug DesignDrug DiscoveryMolecular Cell BiologyChemical Probe DiscoveryLigand BindingMolecular Probe DevelopmentProtein TargetingChemoselective CouplingChemoselective FunctionalizationKinase Activity ProfilingKinase ProbesKinase Selectivity ProfilingLysine ConjugationProtein CrystallographyTargeted Kinase Inhibition
Protein kinases comprise a large family of structurally related enzymes. A major goal in kinase-inhibitor development is to selectively engage the desired kinase while avoiding myriad off-target kinases. However, quantifying inhibitor interactions with multiple endogenous kinases in live cells remains an unmet challenge. Here, we report the design of sulfonyl fluoride probes that covalently label a broad swath of the intracellular kinome with high efficiency. Protein crystallography and mass spectrometry confirmed a chemoselective reaction between the sulfonyl fluoride and a conserved lysine in the ATP binding site. Optimized probe 2 (XO44) covalently modified up to 133 endogenous kinases, efficiently competing with high intracellular concentrations of ATP. We employed probe 2 and label-free mass spectrometry to quantify intracellular kinase engagement by the approved drug, dasatinib. The data revealed saturable dasatinib binding to a small subset of kinase targets at clinically relevant concentrations, highlighting the utility of lysine-targeted sulfonyl fluoride probes in demanding chemoproteomic applications.
29
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations
A small molecule–kinase interaction map for clinical kinase inhibitors
Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text
Oliver Borst, Britta Walker, Patrick Münzer et al. · Cellular Physiology and Biochemistry · 2013 · 1.9K citations · Full text